Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Kani Khalaf, Sten Axelsson Fisk, Ann Ekberg-Jansson, George Leckie, Raquel Perez-Vicente & Juan Merlo. (2020) Geographical and sociodemographic differences in discontinuation of medication for Chronic Obstructive Pulmonary Disease – A Cross-Classified Multilevel Analysis of Individual Heterogeneity and Discriminatory Accuracy (MAIHDA). Clinical Epidemiology 12, pages 783-796.
Read now
Read now
Mario Cazzola, Francesco Cavalli, Omar S. Usmani & Paola Rogliani. (2020) Advances in pulmonary drug delivery devices for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Delivery 17:5, pages 635-646.
Read now
Read now
José Luis López-Campos, Esther Quintana Gallego & Laura Carrasco Hernández. (2019) Status of and strategies for improving adherence to COPD treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1503-1515.
Read now
Read now
Todd P. Gilmer, Bartolome R. Celli, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Maryam Navaie. (2019) Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease*. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 140-151.
Read now
Read now
Kirsten Koehorst-ter Huurne, Marjolein Brusse-Keizer, Paul van der Valk, Kris Movig, Job van der Palen & Christina Bode. (2018) Patients with underuse or overuse of inhaled corticosteroids have different perceptions and beliefs regarding COPD and inhaled medication. Patient Preference and Adherence 12, pages 1777-1783.
Read now
Read now
Kirsten Koehorst-ter Huurne, Catharina GM Groothuis-Oudshoorn, Paul DLPM vanderValk, Kris LL Movig, Job van der Palen & Marjolein Brusse-Keizer. (2018) Association between poor therapy adherence to inhaled corticosteroids and tiotropium and morbidity and mortality in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1683-1690.
Read now
Read now
Luigino Calzetta, Chiara Ciaprini, Ermanno Puxeddu & Mario Cazzola. (2016) Olodaterol + tiotropium bromide for the treatment of COPD. Expert Review of Respiratory Medicine 10:4, pages 379-386.
Read now
Read now
Articles from other publishers (13)
Wei Wei, Dong Wang, Weiting Liu, Hui Du, Zhiye Zhang, Shengying Che, Rui Ding & YanBiao Yang. (2023) Skills in handling Turbuhaler, Diskus in the west of China. BMC Pulmonary Medicine 23:1.
Crossref
Crossref
Heba Banat, Rita Ambrus & Ildikó Csóka. (2023) Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance. International Journal of Pharmaceutics 643, pages 123070.
Crossref
Crossref
Natacha Biset, Mélanie Lelubre, Stéphanie Pochet & Carine De Vriese. (2023) Asthma and COPD: Comparison with International Guidelines and Medication Adherence in Belgium. Pharmaceuticals 16:7, pages 1030.
Crossref
Crossref
Omar S. Usmani, Anthony J. Hickey, Deniz Guranlioglu, Kacey Rawson, Neda Stjepanovic, Shahid Siddiqui & Rajiv Dhand. (2021) The Impact of Inhaler Device Regimen in Patients with Asthma or COPD. The Journal of Allergy and Clinical Immunology: In Practice 9:8, pages 3033-3040.e1.
Crossref
Crossref
E. López-Pintor, J. Grau, I. González, MC Bernal-Soriano, J.A. Quesada & B. Lumbreras. (2021) Impact of patients’ perception of COPD and treatment on adherence and health-related quality of life in real-world: Study in 53 community pharmacies. Respiratory Medicine 176, pages 106280.
Crossref
Crossref
Maryam Navaie, Carole Dembek, Soojin Cho-Reyes, Karen Yeh & Bartolome R. Celli. (2020) Inhaler device feature preferences among patients with obstructive lung diseases. Medicine 99:25, pages e20718.
Crossref
Crossref
Takashi Iwanaga, Yuji Tohda, Shuhei Nakamura & Yasunori Suga. (2019) The Respimat® Soft Mist Inhaler: Implications of Drug Delivery Characteristics for Patients. Clinical Drug Investigation 39:11, pages 1021-1030.
Crossref
Crossref
F. Dalon, E. Van Ganse, C. Correia Da Silva, G. Nachbaur, L. Saïl & M. Belhassen. (2019) Revue générale sur l’adhésion aux traitements inhalés de la BPCO. Revue des Maladies Respiratoires 36:7, pages 801-849.
Crossref
Crossref
Ju-Hee Park, Yunjung Kim, Seongmi Choi, Eun Jin Jang, Jimin Kim, Chang-Hoon Lee, Jae-Joon Yim, Ho-il Yoon & Deog Kyeom Kim. (2019) Risk for pneumonia requiring hospitalization or emergency room visit according to delivery device for inhaled corticosteroid/long-acting beta-agonist in patients with chronic airway diseases as real-world evidence. Scientific Reports 9:1.
Crossref
Crossref
Suzanne G. Bollmeier, Terry L. Seaton, Theresa R. Prosser, Yi-Ting Chou, Kristine Reckenberg, Beth Hahn, Richard H. Stanford & Riju Ray. (2019) Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting. Journal of the American Pharmacists Association 59:4, pages 479-488.e1.
Crossref
Crossref
Magda Vytrisalova, Tereza Hendrychova, Tereza Touskova, Eva Zimcikova, Jiri Vlcek, Libor Nevoranek, Michal Svoboda, Karel Hejduk, Kristian Brat, Marek Plutinsky, Barbora Novotna, Pavlina Musilova, Matej Cernohorsky & Vladimir Koblizek. (2019) Breathing Out Completely Before Inhalation: The Most Problematic Step in Application Technique in Patients With Non-Mild Chronic Obstructive Pulmonary Disease. Frontiers in Pharmacology 10.
Crossref
Crossref
Paola Rogliani, Josuel Ora, Ermanno Puxeddu, Maria Gabriella Matera & Mario Cazzola. (2017) Adherence to COPD treatment: Myth and reality. Respiratory Medicine 129, pages 117-123.
Crossref
Crossref
Valeria Belleudi, Mirko Di Martino, Silvia Cascini, Ursula Kirchmayer, Riccardo Pistelli, Giulio Formoso, Danilo Fusco, Marina Davoli & Nera Agabiti. (2016) The impact of adherence to inhaled drugs on 5‐year survival in COPD patients: a time dependent approach. Pharmacoepidemiology and Drug Safety 25:11, pages 1295-1304.
Crossref
Crossref